Home

search

Subjectguide
Journals
Books / Serials / Multimedia
Services
Services

Login for Subscribers
Logout

Sitemap
Help
Contacts


Logo






Vol. 18, No. 3, 2005   

Free Abstract     Article (References)     Article (PDF 356 KB)     

Review

Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action
M. Schäfer-Kortinga, B. Kleusera, M. Ahmeda, H.-D. Höltjeb, H.C. Kortingc

aPharmakologie und Toxikologie, Institut für Pharmazie, Freie Universität Berlin, Berlin,
bPharmazeutische Chemie, Institut für Pharmazie, Heinrich-Heine-Universität, Düsseldorf,
cKlinik und Poliklinik für Dermatologie und Allergologie, Ludwig-Maximilians-Universität, München, Deutschland

Address of Corresponding Author

Skin Pharmacol Physiol 2005;18:103-114 (DOI: 10.1159/000084907)


 goto top of page Key Words

  • Glucocorticoids
  • Genomic effects
  • Glucocorticoid receptor
  • Non-genomic effects
  • Cellular signalling
  • Skin

 goto top of page Abstract

Topical glucocorticoids have always been considered first-line drugs for inflammatory diseases of the skin and bronchial system. Applied systemically, glucocorticoids are used for severe inflammatory and immunological diseases and the inhibition of transplant rejection. Owing to the progress in molecular pharmacology, the knowledge of the mechanism of action has increased during the last years. Besides distinct genomic targets, which are due to the activation of specific cytoplasmatic receptors resulting in the (trans-) activation or (trans-) repression of target genes, there are non-genomic effects on the basis of the interference with membrane-associated receptors as well as with membrane lipids. In fact, various glucocorticoids appear to differ with respect to the relative influence on these targets. Thus, the extended knowledge of glucocorticoid-induced cellular signalling should allow the design and development of even more specifically acting drugs - as it has been obtained with other steroids, e.g. estrogens for osteoporosis prevention.

Copyright © 2005 S. Karger AG, Basel


 goto top of page Author Contacts

Prof. Dr. M. Schäfer-Korting
Institut für Pharmazie (Pharmakologie und Toxikologie)
Freie Universität Berlin, Königin-Luise-Strasse 2-4
DE-14195 Berlin (Deutschland)
Tel. +49 30 838 53283, Fax +49 30 838 54399, E-Mail msk@zedat.fu-berlin.de


 goto top of page Article Information

Received: June 1, 2004
Accepted after revision: October 19, 2004
Number of Print Pages : 12
Number of Figures : 3, Number of Tables : 2, Number of References : 82

 
Journal Home
Journal Content
Guidelines
Editorial Board
Aims and Scope
Subscriptions
Medline Abstract (ID 15897682)
Download Citation
Cited In



This journal is part of the fourth subject package of the Karger

Journal Archive Collection

Information on packages (PDF)
Free sample issues



For non-native English speakers and international authors who would like assistance with their writing before submission, we suggest American Journal Experts for their scientific editing service.





copyright  © 2009 S. Karger AG, Basel